More U.S. patients will have access to a mobile app to track Parkinson's symptoms, as Neu Health joins an incubator program in Houston.| Parkinson's News Today
Advocates gathered in Washington to urge Congress to expand federal funding for Parkinson’s disease research at NIH.| Parkinson's News Today
The first three Parkinson's patients who received ANPD001 saw improvements in motor symptoms and daily functioning, early trial data showed.| Parkinson's News Today
A sweet story has a cringeworthy ending for columnist Christine Scheer, who lost her sense of smell and taste because of Parkinson's.| Parkinson's News Today
Target enrollment is complete for a Phase 1b trial testing the safety and tolerability of GT-02287 in people with Parkinson’s disease.| Parkinson's News Today
Columnist Doc Irish pays tribute to his dog, Jax, in a reflection on aging that also looks at his own life with Parkinson's disease.| Parkinson's News Today
Blood levels of 2 proteins in REM sleep behavior disorder patients linked with later finding of Parkinson's-like disease, Lewy body dementia.| Parkinson's News Today
No description.| Parkinson's News Today
Parkinson’s patients show an inflammatory gut microbiome (bacterial population of the intestines) regardless of disease status or lifestyle.| Parkinson's News Today
Columnist Mollie Lombardi shares how her early-onset Parkinson's disease diagnosis has affected her husband and their marriage.| Parkinson's News Today
When choosing members of your healthcare team, don't settle for just "OK," says columnist Christine Scheer. Advocating for yourself is key.| Parkinson's News Today
Columnist Mary Beth Skylis shares tips for positive coping skills that she encourages her dad, who has Parkinson's, to implement.| Parkinson's News Today
Category archive page for Columns.| Parkinson's News Today
The FDA approved a brain mapping tool that will enable doctors to more precisely use neuromodulation therapies like DBS.| Parkinson's News Today
The first patient has been dosed in a Phase 2a trial of Parkinson's therapy VTX3232, an oral medication designed to reduce inflammation.| Parkinson's News Today
Regeneron joined the data syndication program for the LEARNS study that's assessing digital biomarkers for measuring Parkinson's progression.| Parkinson's News Today
Learn about Parkinson's disease, a condition that affects the brain, resulting in issues with movement, balance, and more.| Parkinson's News Today